FACTBOX-The 20 largest pharmaceutical companies

March 26 (Reuters) - The following is a list of the top 20
pharmaceutical companies, ranked by global prescription drug
sales for the 12 months through September 2009, according to
pharmaceutical market research company IMS Health Inc.

The chart shows sales -- in billions of U.S. dollars -- and
percent change over the period. The data does not include the
results from mega acquisitions by Pfizer (PFE.N) and Merck
(MRK.N), as their deals for Wyeth and Schering-Plough,
respectively, were completed in the fourth quarter.

A year after a wave of mega-mergers shook up the
pharmaceutical industry, the remaining big drugmakers most
often mentioned as takeout or merger candidates appear set to
go it alone as they edge toward their patent cliffs.
[ID:nN26144801]

Company Sales pct change

1) Pfizer $41.7 (0.8)

2) Novartis $36.7 7.0

3) Sanofi-Aventis $35.1 3.3

4) GlaxoSmithKline $34.3 (3.4)

5) AstraZeneca $33.2 7.8

6) Roche $31.3 8.6

7) Johnson & Johnson $26.9 (6.6)

8) Merck & Co $25.0 (4.1)

9) Eli Lilly $19.6 8.3

10) Abbott $19.4 5.5

11) Teva $15.7 12.3

12) Bayer $15.4 3.9

13) Wyeth $14.8 (2.3)

14) Amgen $14.8 (3.1)

15) Boehringer $14.6 10.4

16) Takeda $14.4 2.1

17) Bristol-Myers $14.2 5.8

18) Schering-Plough $13.1 4.3

19) Daiichi Sankyo $8.5 3.1

20) Novo Nordisk $8.2 11.6
(Source: IMS Health)